Mona Gaber

Antiprotozoal activity of silver nanoparticles against Cryptosporidium parvum oocysts: New insights on their feasibility as a water disinfectant

Dalia Hassan, Mohamed Farghali, Hanan E. M. Eldeek et al. · Journal of Microbiological Methods · 2019 · 35 citations

Pharmacy, Infectious Diseases, Toxicology +16

Dengue fever as a reemerging disease in upper Egypt: Diagnosis, vector surveillance and genetic diversity using RT-LAMP assay

Mona Gaber, Alzahraa Abdelraouf Ahmad, Asmaa M. El-Kady et al. · PLoS ONE · 2022 · 26 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum

Mona Gaber, Lamia Galal, Haiam Mohamed Mahmoud Farrag et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2022 · 20 citations · Full text

Medicine, Infectious Diseases, Antimicrobial Pharmacology +4

Virulence of geographically different Cryptosporidium parvum isolates in experimental animal model

Fatma G. Sayed, Amany I. Hamza, Lamia Galal et al. · PubMed · 2016 · 19 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

THE POTENTIAL CONVENTION OF GARLIC AND BLACK SEED DIFFERENT EXTRACTS AS AN EFFECTIVE TREATMENT OF CRYPTOSPORIDIUM SPP. : AN EXPERIMENTAL STUDY

Hesham A. Sadek, Salma M. Abdel-Rahman, Hanna Y. Bakir et al. · Journal of the Egyptian Society of Parasitology · 2020 · 12 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15